• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Comprehensive Overview of 3H-imidazo[4,5-b]pyridine (CAS No. 170245-18-8): Properties, Applications, and Research Insights

3H-imidazo[4,5-b]pyridine (CAS No. 170245-18-8) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and materials science research due to its unique structural framework. The imidazo[4,5-b]pyridine scaffold is a fused bicyclic system combining imidazole and pyridine rings, which contributes to its versatile chemical reactivity and biological activity. Researchers and industries are increasingly exploring its potential in drug discovery, particularly for targeting kinase inhibitors and modulating enzymatic pathways.

The compound’s molecular structure, characterized by the imidazo[4,5-b]pyridine core, enables it to interact with various biological targets. This has led to its investigation in the development of therapeutics for conditions such as inflammation, cancer, and neurodegenerative diseases. Recent studies highlight its role in the design of small-molecule inhibitors, where its ability to form hydrogen bonds and π-π stacking interactions enhances binding affinity. The CAS 170245-18-8 derivative is also being studied for its optoelectronic properties, making it relevant in the field of organic electronics.

In the context of current trends, the demand for imidazo[4,5-b]pyridine derivatives has surged due to their applicability in precision medicine and personalized therapeutics. Search engine analytics reveal growing queries such as "3H-imidazo[4,5-b]pyridine synthesis" and "CAS 170245-18-8 applications," reflecting the compound’s relevance in academic and industrial research. Additionally, its potential in green chemistry aligns with the global push for sustainable synthetic methodologies, further driving interest.

From a synthetic perspective, 3H-imidazo[4,5-b]pyridine can be prepared via multicomponent reactions or cyclization strategies, often involving catalytic systems to improve yield and selectivity. Innovations in catalytic C-H functionalization have streamlined access to its derivatives, addressing challenges related to regioselectivity. The compound’s stability under physiological conditions also makes it a promising candidate for prodrug development, a topic frequently searched in medicinal chemistry forums.

Beyond pharmaceuticals, CAS 170245-18-8 is explored in materials science for its luminescent properties. Its π-conjugated system enables applications in organic light-emitting diodes (OLEDs) and sensors. Researchers are optimizing its photophysical characteristics to enhance device efficiency, a subject of high interest in renewable energy discussions. This dual utility in life sciences and advanced materials underscores its interdisciplinary importance.

In summary, 3H-imidazo[4,5-b]pyridine (CAS No. 170245-18-8) represents a pivotal building block in modern chemistry. Its adaptability across drug design, catalysis, and optoelectronics positions it at the forefront of innovation. As scientific inquiries evolve, this compound will likely remain a focal point for breakthroughs in targeted therapy and sustainable technology.

• 32106-04-0(Imidazo[4,5-c]pyridine(6CI,9CI))
• 132898-03-4(3H-Imidazo4,5-bpyridin-2-ylamine)
• 322-46-3(Pyrido[2,3-b]pyrazine)
• 502422-99-3(1H-Imidazo[2,1:2,3]imidazo[4,5-b]pyridine(9CI))
• 946387-54-8(3H-Imidazo[4',5':5,6]pyrido[3,2-d]pyrimidine)
• 216382-88-6(Imidazopyridine)
• 273-21-2(4-Azabenzimidazole)
• 257285-76-0(1H-Imidazo[4,5-c][2,7]naphthyridine (9CI))
• 245-72-7(Dipyrido[1,2-a:3',2'-d]imidazole)
• 170245-19-9(4H-Imidazo4,5-bpyridine)